IMMUNOME INC (IMNM)
US45257U1088 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to IMNM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.16. This target is 4.48% above the current price.
IMNM was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about IMNM.
In the previous month the buy percentage consensus was at a similar level.
IMNM was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-03-20 | Cantor Fitzgerald | Reiterate | Overweight |
| 2023-03-17 | Chardan Capital | Maintains | Buy |
| 2021-10-29 | Cantor Fitzgerald | Initiate | Overweight |